Get access to our best features
Get access to our best features
Published 3 years ago

FDA panel recommends COVID-19 boosters only for those 65 and older or at high risk

Summary
After hours of discussion and a request to revise the question they were being asked, a key federal advisory committee on Friday agreed to a third dose of the Pfizer-BioNTech COVID-19 vaccine six months after full vaccination for people aged 65 and older and those at high risk of severe COVID-19.

0 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • 53% of the sources are Center
52% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)